Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor
Open Access

Theranostic Digital Twins: An Indispensable Prerequisite for Personalized Cancer Care

Julia Brosch-Lenz, Carlos Uribe, Arman Rahmim and Babak Saboury
Journal of Nuclear Medicine March 2023, 64 (3) 501; DOI: https://doi.org/10.2967/jnumed.122.264929
Julia Brosch-Lenz
BC Cancer Research Institute Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Uribe
BC Cancer Research Institute Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arman Rahmim
BC Cancer Research Institute Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Babak Saboury
BC Cancer Research Institute Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 3 501
DOI 
https://doi.org/10.2967/jnumed.122.264929
PubMed 
36863782

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online March 2, 2023.

Article Versions

  • previous version (December 8, 2022 - 12:32).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

Statistics from Altmetric.com

Cited By...

  • 11 Citations
  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies
    Julia Franziska Brosch-Lenz, Astrid Delker, Fabian Schmidt, Johannes Tran-Gia
    Nuklearmedizin - NuclearMedicine 2023 62 06
  • Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins
    Lidia Strigari, Jazmin Schwarz, Tyler Bradshaw, Julia Brosch-Lenz, Geoffrey Currie, Georges El-Fakhri, Abhinav K. Jha, Signe Mežinska, Neeta Pandit-Taskar, Emilie Roncali, Kuangyu Shi, Carlos Uribe, Tahir Yusufaly, Habib Zaidi, Arman Rahmim, Babak Saboury
    Journal of Nuclear Medicine 2025 66 5
  • Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
    Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, Carlos Uribe, Abhinav K. Jha, Geoffrey Currie, Joyita Dutta, Georges El-Fakhri, Helena McMeekin, Neeta Pandit-Taskar, Jazmin Schwartz, Kuangyu Shi, Lidia Strigari, Habib Zaidi, Babak Saboury, Arman Rahmim
    Journal of Nuclear Medicine 2025 66 4
  • Sharpening the Blade of Precision Theranostics
    Geoffrey M. Currie, Eric M. Rohren
    Seminars in Nuclear Medicine 2025
  • Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in 177Lu-PSMA Therapy
    Hamid Abdollahi, Ali Fele-Paranj, Arman Rahmim
    Cancers 2024 16 18
  • Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
    Aryan Golzaryan, M. Soltani, Farshad Moradi Kashkooli, Babak Saboury, Arman Rahmim
    Scientific Reports 2025 15 1
  • Pervasive Computing Technologies for Healthcare
    Dionysia Chrysanthakopoulou, Constantinos Koutsojannis
    2025 611

Article usage

Article usage: December 2022 to April 2025

AbstractFullPdf
Dec 202200213
Jan 20230084
Feb 20230043
Mar 20230677125
Apr 2023032047
May 2023025142
Jun 2023021647
Jul 2023023115
Aug 2023033651
Sep 2023027525
Oct 2023013436
Nov 202308944
Dec 202305136
Jan 2024020136
Feb 2024019824
Mar 2024012220
Apr 202404517
May 202406734
Jun 202409353
Jul 2024011328
Aug 2024010849
Sep 202405229
Oct 202405730
Nov 202402618
Dec 202403225
Jan 202501636
Feb 202508045
Mar 202505119
Apr 202505633
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (3)
Journal of Nuclear Medicine
Vol. 64, Issue 3
March 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Theranostic Digital Twins: An Indispensable Prerequisite for Personalized Cancer Care
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Theranostic Digital Twins: An Indispensable Prerequisite for Personalized Cancer Care
Julia Brosch-Lenz, Carlos Uribe, Arman Rahmim, Babak Saboury
Journal of Nuclear Medicine Mar 2023, 64 (3) 501; DOI: 10.2967/jnumed.122.264929

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Theranostic Digital Twins: An Indispensable Prerequisite for Personalized Cancer Care
Julia Brosch-Lenz, Carlos Uribe, Arman Rahmim, Babak Saboury
Journal of Nuclear Medicine Mar 2023, 64 (3) 501; DOI: 10.2967/jnumed.122.264929
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Improving dosage and timing of radiopharmaceutical therapies using computational modeling of tumor and radioligand dynamics
  • Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins
  • Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
  • Google Scholar

More in this TOC Section

  • Reply to “The Randomized, Phase 2 LuCAP Study”
  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire